| 摘要 |
The invention relates to a process for the manufacture of enantiomerically enriched or pure compounds of formula (I)wherein R, R, R, R, Rand Q are defined as in claim 1 as well as their crystalline forms for the treatment of proliferative diseases such as cancer. |
